(IR) Ingersoll Rand - Ratings and Ratios
Compressor, Pump, Blower, Vacuum, Tool
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.3% |
| Value at Risk 5%th | 42.4% |
| Relative Tail Risk | -5.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.02 |
| Alpha | -43.67 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.384 |
| Beta | 1.177 |
| Beta Downside | 1.120 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.62% |
| Mean DD | 9.11% |
| Median DD | 5.19% |
Description: IR Ingersoll Rand October 14, 2025
Ingersoll Rand Inc. (NYSE: IR) is a diversified industrial-technology firm that delivers mission-critical air, fluid, energy, and medical solutions worldwide through two primary segments: Industrial Technologies & Services and Precision & Science Technologies.
The Industrial Technologies & Services segment manufactures and services air- and gas-compression, vacuum, blower, fluid-transfer, power-tool, and lifting-equipment product lines, along with aftermarket parts and services, under brands such as Ingersoll Rand, Gardner Denver, Nash, CompAir, and Elmo Rietschle.
The Precision & Science Technologies segment focuses on high-precision dosing and fluid-handling equipment-including diaphragm, piston, peristaltic, and progressive-cavity pumps, hydrogen compressors, and automated liquid-handling systems-served to medical, laboratory, life-science, industrial manufacturing, water-treatment, chemical, energy, food-beverage, and agricultural markets under a broad portfolio of brands (e.g., Air Dimensions, Haskel, Milton Roy, Seepex).
Key quantitative signals (FY 2023) include total revenue of approximately $15.2 billion, an adjusted EBITDA margin of roughly 14 %, and a free-cash-flow conversion of 70 % of EBITDA, reflecting strong cash generation despite a cyclical industrial backdrop. The global compressed-air market is projected to grow at a 4 % CAGR through 2029, while demand for hydrogen-compression systems is accelerating as green-hydrogen projects expand-both trends that underpin IR’s growth outlook.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of IR’s cash-flow trends and peer-relative valuation multiples.
IR Stock Overview
| Market Cap in USD | 30,107m |
| Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2017-05-12 |
| Return 12m vs S&P 500 | -36.7% |
| Analyst Rating | 3.94 of 5 |
IR Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 0.11% |
| Yield on Cost 5y | 0.18% |
| Yield CAGR 5y | -47.59% |
| Payout Consistency | 82.4% |
| Payout Ratio | 2.5% |
IR Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 11.41% |
| CAGR/Max DD Calmar Ratio | 0.31 |
| CAGR/Mean DD Pain Ratio | 1.25 |
| Current Volume | 2939k |
| Average Volume | 2939k |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (545.1m TTM) > 0 and > 6% of Revenue (6% = 447.5m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.00% (prev 33.75%; Δ -3.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.38b > Net Income 545.1m (YES >=105%, WARN >=100%) |
| Net Debt (3.68b) to EBITDA (1.66b) ratio: 2.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (400.5m) change vs 12m ago -1.57% (target <= -2.0% for YES) |
| Gross Margin 43.72% (prev 43.81%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.98% (prev 39.32%; Δ 1.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.69 (EBITDA TTM 1.66b / Interest Expense TTM 250.8m) >= 6 (WARN >= 3) |
Altman Z'' 2.09
| (A) 0.12 = (Total Current Assets 4.16b - Total Current Liabilities 1.93b) / Total Assets 18.19b |
| (B) 0.15 = Retained Earnings (Balance) 2.79b / Total Assets 18.19b |
| (C) 0.06 = EBIT TTM 1.18b / Avg Total Assets 18.20b |
| (D) 0.33 = Book Value of Equity 2.63b / Total Liabilities 8.00b |
| Total Rating: 2.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.15
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 3.87% = 1.94 |
| 3. FCF Margin 17.53% = 4.38 |
| 4. Debt/Equity 0.48 = 2.39 |
| 5. Debt/Ebitda 2.21 = -0.41 |
| 6. ROIC - WACC (= -3.02)% = -3.77 |
| 7. RoE 5.33% = 0.44 |
| 8. Rev. Trend 81.28% = 6.10 |
| 9. EPS Trend 61.70% = 3.09 |
What is the price of IR shares?
Over the past week, the price has changed by -4.61%, over one month by -4.57%, over three months by -6.59% and over the past year by -27.45%.
Is IR a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 88.1 | 19.6% |
| Analysts Target Price | 88.1 | 19.6% |
| ValueRay Target Price | 72.7 | -1.3% |
IR Fundamental Data Overview November 17, 2025
P/E Trailing = 55.9037
P/E Forward = 20.5761
P/S = 4.0368
P/B = 2.9458
P/EG = 0.9992
Beta = 1.331
Revenue TTM = 7.46b USD
EBIT TTM = 1.18b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 65.6m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.68b USD (from netDebt column, last quarter)
Enterprise Value = 33.78b USD (30.11b + Debt 4.85b - CCE 1.18b)
Interest Coverage Ratio = 4.69 (Ebit TTM 1.18b / Interest Expense TTM 250.8m)
FCF Yield = 3.87% (FCF TTM 1.31b / Enterprise Value 33.78b)
FCF Margin = 17.53% (FCF TTM 1.31b / Revenue TTM 7.46b)
Net Margin = 7.31% (Net Income TTM 545.1m / Revenue TTM 7.46b)
Gross Margin = 43.72% ((Revenue TTM 7.46b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 43.74% (prev 43.69%)
Tobins Q-Ratio = 1.86 (Enterprise Value 33.78b / Total Assets 18.19b)
Interest Expense / Debt = 1.34% (Interest Expense 65.1m / Debt 4.85b)
Taxrate = 23.04% (73.6m / 319.4m)
NOPAT = 905.4m (EBIT 1.18b * (1 - 23.04%))
Current Ratio = 2.16 (Total Current Assets 4.16b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.85b / totalStockholderEquity, last quarter 10.12b)
Debt / EBITDA = 2.21 (Net Debt 3.68b / EBITDA 1.66b)
Debt / FCF = 2.81 (Net Debt 3.68b / FCF TTM 1.31b)
Total Stockholder Equity = 10.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.00% (Net Income 545.1m / Total Assets 18.19b)
RoE = 5.33% (Net Income TTM 545.1m / Total Stockholder Equity 10.22b)
RoCE = 7.84% (EBIT 1.18b / Capital Employed (Equity 10.22b + L.T.Debt 4.79b))
RoIC = 6.04% (NOPAT 905.4m / Invested Capital 14.99b)
WACC = 9.06% (E(30.11b)/V(34.96b) * Re(10.35%) + D(4.85b)/V(34.96b) * Rd(1.34%) * (1-Tc(0.23)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 74.31% ; FCFE base≈1.33b ; Y1≈1.64b ; Y5≈2.80b
Fair Price DCF = 81.76 (DCF Value 32.30b / Shares Outstanding 395.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 61.70 | EPS CAGR: 6.67% | SUE: -0.23 | # QB: 0
Revenue Correlation: 81.28 | Revenue CAGR: 6.99% | SUE: 0.22 | # QB: 0
Additional Sources for IR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle